Gui zhi fu ling wan
Food supplement declared in France, declaration No 2023-9-1045, decision dated 19 September 2023
Gui zhi fu ling wan is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 2 points in its composition require a check (prohibited substance, dose or novel food).
- Brand
- not provided
- Food business operator placing the product on the market
- Calebasse
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Gélule
- Daily dose
- 3 g
- Directions for use
- 3g soit 6 gélules
- Not recommended for (according to the manufacturer)
- Adolescents (moins de 18 ans), Femmes allaitantes, Enfants (moins de 12 ans), Enfants en bas âge (1 à 3 ans), Femmes enceintes, Nourrissons (moins de 1 an)
- Objectives stated by the manufacturer (these are not authorised claims)
- Cycles féminins
Declaration 312516, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- À vérifier
Paeonia spp. (zie ook lijst 3/voir aussi liste 3): dangerous plant prohibited in food in Belgium (list 1). The entire genus Paeonia is listed. List 3 also covers Paeonia x suffruticosa Andrews, parts: racine. Check the plant part used, the preparation, the conditions and the product notification.
Source: Belgium, Royal Decree of 31 August 2021, plant lists (annex replaced on 30 January 2024), arrêté royal du 31 août 2021, annexe remplacée le 30 janvier 2024, liste 1, page PDF 78 ; liste 3, pages PDF 207.
- À vérifier
Paeonia spp. (zie ook lijst 3/voir aussi liste 3): dangerous plant prohibited in food in Belgium (list 1). The entire genus Paeonia is listed. List 3 also covers Paeonia lactiflora Pall., parts: fleur, racine, graine. L'étiquetage doit comporter l’avertissement suivant : Ne pas utiliser en cas de grossesse. Check the plant part used, the preparation, the conditions and the product notification.
Source: Belgium, Royal Decree of 31 August 2021, plant lists (annex replaced on 30 January 2024), arrêté royal du 31 août 2021, annexe remplacée le 30 janvier 2024, liste 1, page PDF 78 ; liste 3, pages PDF 206.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Cinnamomum verum J. Presl | Ecorce | Extrait sec aqueux | 0.6 g |
| Paeonia × suffruticosa Andrews | Ecorce | Extrait sec aqueux | 0.6 g |
| Paeonia lactiflora Pall. | Racine | Extrait sec aqueux | 0.6 g |
| Prunus persica (L.) Stokes | Graine | Extrait sec aqueux | 0.6 g |
| Wolfiporia cocos (F.A. Wolf) Ryvarden & Gilb. | Sclérote | Extrait sec aqueux | 0.6 g |
Additives
E1204
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
Déconseillé en cas d'allergie connue, en particulier avec le baume du Pérou.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Cinnamomum verum J. Presl
Read the warning, when it applies and the studies cited
Cinnamon - Cinnamomum Verum
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Blumenthal et al. 2000; WHO 1999).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: All products except antioxidants.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Contraindications
Do not use if you are pregnant (Brinker 2010; BHC 2006; Blumenthal 2000).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- GUI ZHI FU LING WAN sinopharma, declared in 2024 : different composition: 1 ingredient(s) added, 2 missing
- Gui zhi fu ling wan Laboratoire Calebasse, declared in 2023 : different composition: 0 ingredient(s) added, 1 missing
- Gui zhi fu ling wan Calebasse, declared in 2022 : different composition: 0 ingredient(s) added, 1 missing
- Gui zhi fu ling wan Calebasse, declared in 2022 : different composition: 0 ingredient(s) added, 2 missing
- Gui zhi fu ling wan Calebasse verte, declared in 2020 : different composition: 1 ingredient(s) added, 1 missing
- Gui zhi fu ling wan Calebasse verte, declared in 2019 : different composition: 1 ingredient(s) added, 1 missing
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.